FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to pulmonology, and concerns a drug for treating inflammatory and obstructive respiratory diseases, particularly bronchial asthma and obstructive bronchitis, based on 1,3'-dinitroglycerine ester of 11(S),15(S)-dihydroxy-9-keto-5Z,13E-prostadiene acid, possessing a pronounced bronchodilatory effect. What is considered is a method of treating the inflammatory and obstructive respiratory diseases using the drug based on 1,3'-dinitroglycerine ester of 11(S),15(S)-dihydroxy-9-keto-5Z,13E-prostadiene acid.
EFFECT: invention provides extending the range of the broncholytic drugs ensured by using a natural prostaglandin E2 derivative characterized by higher biological activity and no observable side effects.
2 cl, 4 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS FOR INHALATIONS CONTAINING NITROPROSTON | 2017 |
|
RU2662099C1 |
| ORGANIC COMPOUNDS | 2001 |
|
RU2292890C2 |
| COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATING INFLAMMATORY AND OBSTRUCTIVE RESPIRATORY DISEASES | 2005 |
|
RU2438660C2 |
| AGENT FOR TREATING CHRONIC OBLITERATING PERIPHERAL VASCULAR DISEASES BASED ON PROSTAGLANDIN | 2018 |
|
RU2695068C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ARFORMOTEROL AND FLUTICASONE FUROATE | 2013 |
|
RU2678992C2 |
| COMPOSITIONS COMPRISING FORMOTEROL AND THIOTROPIUM SALT | 2000 |
|
RU2238085C2 |
| COMPOSITIONS INCLUDING FORMOTEROL AND FLUCTICASON PROPIONATE INDICATED FOR TREATING ASTHMA | 2000 |
|
RU2249454C2 |
| MEDICINAL AGENT AND PHARMACEUTICAL SET DESIGNATED FOR ASTHMA TREATMENT | 2000 |
|
RU2270670C2 |
| PROCESS FOR PREPARING DERIVATIVES OF 9-CHLOROPROSTANE OR THEIR SALTS | 0 |
|
SU1026652A3 |
| TROVENTOL-BASED COMPOSITION | 2006 |
|
RU2457832C2 |
